In one paragraphArticle in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Stephanie SembillPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.ORCID https://orcid.org/0009-0006-3394-8959 Thomas ZerjatkeInstitute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine TUD Dresden University of Technology Dresden Germany.
Micha WintersteinPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.
Tabita GhetePediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.ORCID https://orcid.org/0009-0005-8602-3020 Elke SchirmerPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.
Zofia WotschofskyPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.
Manuela KrumbholzPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.
Axel KarowPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.ORCID https://orcid.org/0000-0003-3963-7271 Ingmar GlaucheInstitute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine TUD Dresden University of Technology Dresden Germany.
Markus MetzlerPediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen Germany.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID41939249
PMCPMC13045481
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390